Diagnosis and Individualized Treatment of Three Primary Malignant Tumors: A Case Report
Fang He,1 Yunxia Xia,1 Xiaoling Ling2 1The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, Gansu, People’s Republic of China; 2Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, 730000, Gansu, People’s Republic of ChinaCorrespondence: Xiaoling LingDepar...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de383eb585e14249bcd7f573f80d9afa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sumario: | Fang He,1 Yunxia Xia,1 Xiaoling Ling2 1The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, Gansu, People’s Republic of China; 2Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, 730000, Gansu, People’s Republic of ChinaCorrespondence: Xiaoling LingDepartment of Oncology, The First Hospital of Lanzhou University, Lanzhou, 730000, Gansu, People’s Republic of ChinaTel +86 18693165668Email ldyy_lingxl@Lzu.edu.cnAbstract: Continuous optimization of diagnosis and treatment of malignant tumors has led to significantly prolonged survival in cancer patients. Despite the recent increase in the incidence of multiple primary malignant tumors (MPMT), it remains rare in clinical practice; therefore, normative guidance on its etiology, diagnosis, and treatment is insufficient. Here we describe the case of a patient with three primary malignant tumors, namely breast cancer, diffuse astrocytoma, and hepatic malignant perivascular epithelioid cell tumors (PEComa) and discuss relevant literature.Keywords: multiple primary malignant tumors, breast cancer, diffuse astrocytoma, liver malignant PEComa, etiology, prognosis |
---|